What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Thierry Brue mainly investigates Internal medicine, Endocrinology, Context, Mutation and Adenoma. He combines topics linked to Surgery with his work on Internal medicine. As a part of the same scientific family, he mostly works in the field of Endocrinology, focusing on Adverse effect and, on occasion, Adrenal insufficiency.
His Mutation research is multidisciplinary, relying on both Basal, Germline and Exon. His Adenoma study incorporates themes from Incidence, Macroprolactin, Liter, Gestation and Prospective cohort study. His research in Pituitary gland intersects with topics in Cellular differentiation, T-box, Phenotype, Transcription factor and Gene.
His most cited work include:
- Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas (510 citations)
- A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. (447 citations)
- Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families (255 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Endocrinology, Acromegaly, Hypopituitarism and Pituitary gland. His work investigates the relationship between Internal medicine and topics such as Gastroenterology that intersect with problems in Randomized controlled trial. His Endocrinology research incorporates themes from Mutation and Transcription factor.
His Mutation research includes elements of Phenotype and Exon. His Acromegaly research is multidisciplinary, incorporating elements of Diabetes mellitus, Adverse effect and Pediatrics. He interconnects Surgery and Pituitary tumors in the investigation of issues within Adenoma.
He most often published in these fields:
- Internal medicine (65.32%)
- Endocrinology (56.23%)
- Acromegaly (18.86%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (65.32%)
- Endocrinology (56.23%)
- Acromegaly (18.86%)
In recent papers he was focusing on the following fields of study:
Thierry Brue mostly deals with Internal medicine, Endocrinology, Acromegaly, Pediatrics and Pituitary adenoma. The Internal medicine study combines topics in areas such as Gastroenterology and Oncology. His work deals with themes such as Cushing's disease, Disease and Receptor, which intersect with Endocrinology.
His Acromegaly research is multidisciplinary, relying on both Diabetes mellitus, Adenoma, Signs and symptoms and Somatostatin. His studies in Pediatrics integrate themes in fields like Cabergoline, Blood pressure, Endocrine system, Nausea and Cohort. His Pituitary adenoma research integrates issues from Craniopharyngioma, Surgery and Family history.
Between 2018 and 2021, his most popular works were:
- Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study (32 citations)
- MANAGEMENT OF ENDOCRINE DISEASE: Immune check point inhibitors-induced hypophysitis (23 citations)
- Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study (17 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His primary areas of investigation include Internal medicine, Endocrinology, Pediatrics, Acromegaly and Diabetes mellitus. While working on this project, Thierry Brue studies both Internal medicine and Context. His Endocrinology study combines topics from a wide range of disciplines, such as Concomitant, Prospective cohort study, Adverse effect and Cohort study.
His Pediatrics study also includes fields such as
- Cohort, which have a strong connection to Retrospective cohort study, Natural history, Multiple endocrine neoplasia type 2b, Survival rate and Growth hormone deficiency,
- Endocrine system that intertwine with fields like Central hypothyroidism, Adrenocorticotropic hormone deficiency and Hypopituitarism. His study in Acromegaly is interdisciplinary in nature, drawing from both Odds ratio, Oral administration, Adenoma, Gastroenterology and Mucocutaneous zone. In his study, MEDLINE, Surveillance study, Pegvisomant and Safety surveillance is strongly linked to Observational study, which falls under the umbrella field of Diabetes mellitus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
